David Schlanger Net Worth

The estimated Net Worth of David J Schlanger is at least $50.8 million dollars as of 1 April 2024. Mr. Schlanger owns over 1,000 units of Progyny Inc stock worth over $1,999,445 and over the last 8 years he sold PGNY stock worth over $43,885,549. In addition, he makes $4,964,200 as Chief Executive Officer et Director at Progyny Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Schlanger PGNY stock SEC Form 4 insiders trading

David has made over 79 trades of the Progyny Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he exercised 1,000 units of PGNY stock worth $3,950 on 1 April 2024.

The largest trade he's ever made was selling 960,007 units of Progyny Inc stock on 29 October 2019 worth over $11,731,286. On average, David trades about 80,037 units every 19 days since 2016. As of 1 April 2024 he still owns at least 87,312 units of Progyny Inc stock.

You can see the complete history of Mr. Schlanger stock trades at the bottom of the page.

David Schlanger biography

David Schlanger serves as Chief Executive Officer, Director of the Company. He has served as our Chief Executive Officer since January 2017 and on our board of directors since March 2017. From August 2013 until September 2016, he served as the Chief Executive Officer of WebMD Health Corp., or WebMD. Prior to that, he served as the Interim Chief Executive Officer and in various other senior executive positions at WebMD and predecessor companies for more than 15 years, including as Senior Vice President, Strategic and Corporate Development and Senior Vice President, Corporate Development. Mr. Schlanger received his B.S. from Georgetown University and his J.D. from the University of Michigan Law School.

What is the salary of David Schlanger?

As the Chief Executive Officer et Director of Progyny Inc, the total compensation of David Schlanger at Progyny Inc is $4,964,200. There are no executives at Progyny Inc getting paid more.

How old is David Schlanger?

David Schlanger is 60, he's been the Chief Executive Officer et Director of Progyny Inc since 2017. There are 5 older and 11 younger executives at Progyny Inc. The oldest executive at Progyny Inc is Norman Payson, 72, who is the Independent Director.

What's David Schlanger's mailing address?

David's mailing address filed with the SEC is C/O PROGYNY, INC., 1359 BROADWAY, 2ND FL, NEW YORK, NY, 10018.

Insiders trading at Progyny Inc

Over the last 5 years, insiders at Progyny Inc have traded over $949,717,514 worth of Progyny Inc stock and bought 76,923 units worth $999,999 . The most active insiders traders include Group Holdings (Sbs) Adviso..., Plc Gsk et Gp A, Llcbonderman Davidcou.... On average, Progyny Inc executives and independent directors trade stock every 4 days with the average trade being worth of $2,005,422. The most recent stock trade was executed by Michael E Sturmer on 16 July 2024, trading 9,030 units of PGNY stock currently worth $270,900.

What does Progyny Inc do?

progyny is the leading fertility benefits company that combines service, science, technology and data to provide fertility solutions for self-insured employers. progyny’s approach offers members a comprehensive value based treatment plan that is based on the latest medical science and technology. the benefit plans are designed to improve outcomes, shorten time to pregnancy and reduce total fertility-related costs. progyny supports all fertility solutions to include ivf, iui, embryo banking, egg freezing, adoption and surrogacy.

Complete history of Mr. Schlanger stock trades at Progyny Inc

Progyny Inc executives and stock owners

Progyny Inc executives and other stock owners filed with the SEC include:

• David Schlanger,
  Chief Executive Officer, Director
• Peter Anevski,
  President, Chief Operating Officer
• David J. Schlanger,
  Exec. Chairman
• Peter Anevski,
  Chief Exec. Officer
• Mark S. Livingston,
  Chief Financial Officer
• Jennifer Bealer,
  Exec. VP, Gen. Counsel & Sec.
• Jeffrey Park,
  Independent Director
• Cheryl Scott,
  Independent Director
• Kevin Gordon,
  Independent Director
• Beth Seidenberg,
  Independent Chairman of the Board of Directors
• Norman Payson,
  Independent Director
• Frederick Cohen,
  Independent Director
• Roger Holstein,
  Director
• Malissia Clinton,
  Director
• Lisa Greenbaum,
  Executive Vice President, Chief Client Officer
• Jennifer Bealer,
  Executive Vice President, General Counsel
• Mark Livingston,
  Chief Financial Officer, Principal Accounting Officer
• Julie Stadlbauer,
  Exec. VP of Strategic Sales & Partnerships
• Michael Sturmer,
  Pres
• Cassandra Pratt,
  Sr. VP of People
• Risa Fisher,
  Exec. VP of Marketing & Communication
• James Hart,
  VP of Investor Relations
• Fred E Cohen,
  Director
• Xiii Associates, Llc Kpcb,
  10% owner
• Karin Ajmani,
  EVP, Chief of Strategic Dev.
• Perkins Caufield & Byers Xi...,
  
• Plc Gsk,
  10% owner
• Group Holdings (Sbs) Adviso...,
  
• Lloyd H Dean,
  Director
• Gp A, Llcbonderman Davidcou...,
  
• Allison Swartz,
  EVP, GC
• Michael E Sturmer,
  PRESIDENT